Drawing for PHARMACISTS UNBOUND

USPTO serial 88980827

PHARMACISTS UNBOUND

Reviewed by CopyMark Law Group

Reg. 6343502Status 700Renewal
Filing date
Status date
Registration date
May 4, 2021
Examiner
NOVAKOVIC, MIROSLAV
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PHARMACISTS UNBOUND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua G. Gigger

Joshua G. Gigger STOEL RIVES LLP201 SOUTH MAIN STREET, SUITE 1100SALT LAKE CITY, UT 84111UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Pharmaceutical and pharmacy services, namely, processing and dispensing online and telephone prescription orders for online clinical and retail pharmacies; maintaining a registry of national and international databases in the field of pharmaceuticals, medical devices, clinical trials, and healthcare; maintaining databases of pharmacies, pharmacists, and other healthcare professionals who can assist with the delivery of pharmaceutical services; retail pharmacy services; online retail pharmacy services; mail order pharmacy services; promoting the exchange of information and resources within the pharmaceutical, medical device, clinical trial, and medical communities to achieve advances in the fields of clinical research and healthcare; providing a website featuring statistical data and feedback on healthcare provider's performance for the purpose of assisting prospective patients in making physician, pharmacist, and other healthcare professional selection decisions; recruitment advertisement services, namely, posting of clinical trial notices for the purposes of providing clinical trial status, and recruiting and informing patients for participation in clinical trials for the testing of drugs and medical devices; providing needed information on the topics of healthcare operations management for promoting patient satisfaction via a global computer network; global patient relationship management services; and global consulting services in the field of patient relationship management for healthcare providersACTIVEJan 31, 2020
036Pharmacy benefit management servicesACTIVEJan 31, 2020
039Pharmacy packaging services, namely, packaging, labeling, aligning and sorting medication by date and time into individual packages and containers for patients and healthcare professionals; delivery of goods for others, namely, delivery of medication, device and clinical supply packages and containers by date and time and category for patients and healthcare providersACTIVEJan 31, 2020
042Pharmaceutical and medical device services, namely, providing pharmacist medical and scientific research counseling services to patients and healthcare providers as well as patients and healthcare providers participating in clinical trials for pharmaceutical, biotechnology, and medical device development and testing; providing a website featuring online non-downloadable software applications used for providing information about healthcare, and investigational medical devices, diagnostics and pharmaceuticals; providing online, non-downloadable software for use in providing information relating to electronic health records; medical and scientific research information in the field of healthcare; conducting clinical trials for othersACTIVEJan 31, 2020
044Dispensing of medications by date and time and category for patients and healthcare providers; population health services, namely, gathering of global patient healthcare and behavioral data for the benefit of improving healthcare for individual patients, groups of patients, and populations; pharmaceutical advice; preparation of prescriptions in pharmacies; dispensing of pharmaceuticals; providing healthcare information; medical and pharmaceutical consultation; medical and pharmaceutical counseling via online or remote communication means; medical drug monitoring and alert service for healthcare providers and patients, namely, providing medication therapy management, medicinal dosage, allergic sensitivity, and prescription safety information for medical treatment purposes; telemedicine services; telepharmacy services, namely, providing medical and pharmaceutical consultation and advice via online or remote communication means; providing information to patients in the field of administering, use and storage of medications; and providing medical information to patients in the form of reports in the field of pharmaceuticals and medical devicesACTIVEJan 31, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 4, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 6, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 4, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 30, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 27, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 26, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 25, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 25, 2021EX1GSOU EXTENSION 1 GRANTED—
Feb 25, 2021DPCCDIVISIONAL PROCESSING COMPLETE—
Feb 16, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 27, 2021IUAFUSE AMENDMENT FILED—
Jan 27, 2021EXT1SOU EXTENSION 1 FILED—
Jan 27, 2021DRRRDIVISIONAL REQUEST RECEIVED—
Jan 27, 2021ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jan 27, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 27, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 28, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 2, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 2, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 28, 2020ALIEASSIGNED TO LIE—
Apr 22, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 1, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 31, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 31, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 31, 2020GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Mar 31, 2020GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Mar 31, 2020EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Mar 31, 2020CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Mar 26, 2020DOCKASSIGNED TO EXAMINER—
Jan 10, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 10, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance